Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gibbs

Showing results (341-350 of 427) with videos related to

Pageof 43
Sort By:
Cancers|April 12, 2022
Multiparametric <sup>18</sup>F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast CancerLale Umutlu, Julian Kirchner, Nils-Martin Bruckmann, et al.
Clinical Colorectal Cancer|March 13, 2016
Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal CancerHui-Li Wong, Belinda Lee, Kathryn Field, et al.
Clinical Colorectal Cancer|July 8, 2018
Stage-based Variation in the Effect of Primary Tumor Side on All Stages of Colorectal Cancer Recurrence and SurvivalMargaret M Lee, Andrew MacKinlay, Christine Semira, et al.
Gastroenterology|March 18, 2023
Oncomicrobial Community Profiling Identifies Clinicomolecular and Prognostic Subtypes of Colorectal CancerDmitri Mouradov, Paul Greenfield, Shan Li, et al.
British Journal of Cancer|March 6, 2024
Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world dataShehara Mendis, Lara Lipton, Yat Hang To, et al.
BMC Public Health|August 26, 2025
Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic cancer: an analysis of PURPLE real-world registry data from an Australian populationEmma Sanderson, Belinda Lee, Nadia Ayres, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 2015
Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutationNishi Kothari, Richard Kim, Robert N Jorissen, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 21, 2022
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?Amanda Pereira-Salgado, Angelyn Anton, Fanny Franchini, et al.
Internal Medicine Journal|November 18, 2024
Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancerMatthew Loft, Vanessa Wong, Suzanne Kosmider, et al.
Cancers|November 27, 2021
A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant DiseaseAndrew Bakshi, Moeen Riaz, Suzanne G Orchard, et al.
Pageof 43

Showing results (341-350 of 427) with videos related to

Sort By:
Pageof 43
Cancers|April 12, 2022
Multiparametric <sup>18</sup>F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast CancerLale Umutlu, Julian Kirchner, Nils-Martin Bruckmann, et al.
Clinical Colorectal Cancer|March 13, 2016
Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal CancerHui-Li Wong, Belinda Lee, Kathryn Field, et al.
Clinical Colorectal Cancer|July 8, 2018
Stage-based Variation in the Effect of Primary Tumor Side on All Stages of Colorectal Cancer Recurrence and SurvivalMargaret M Lee, Andrew MacKinlay, Christine Semira, et al.
Gastroenterology|March 18, 2023
Oncomicrobial Community Profiling Identifies Clinicomolecular and Prognostic Subtypes of Colorectal CancerDmitri Mouradov, Paul Greenfield, Shan Li, et al.
British Journal of Cancer|March 6, 2024
Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world dataShehara Mendis, Lara Lipton, Yat Hang To, et al.
BMC Public Health|August 26, 2025
Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic cancer: an analysis of PURPLE real-world registry data from an Australian populationEmma Sanderson, Belinda Lee, Nadia Ayres, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 2015
Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutationNishi Kothari, Richard Kim, Robert N Jorissen, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 21, 2022
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?Amanda Pereira-Salgado, Angelyn Anton, Fanny Franchini, et al.
Internal Medicine Journal|November 18, 2024
Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancerMatthew Loft, Vanessa Wong, Suzanne Kosmider, et al.
Cancers|November 27, 2021
A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant DiseaseAndrew Bakshi, Moeen Riaz, Suzanne G Orchard, et al.
Pageof 43